Literature DB >> 25243570

The expression of the miR-25/93/106b family of micro-RNAs in the adipose tissue of women with polycystic ovary syndrome.

Hsiao-Li Wu1, Saleh Heneidi, Tung-Yueh Chuang, Michael P Diamond, Lawrence C Layman, Ricardo Azziz, Yen-Hao Chen.   

Abstract

CONTEXT: In adipose tissue (AT) micro-RNA-93 (miR-93) is significantly overexpressed in polycystic ovary syndrome (PCOS) women and non-PCOS women with insulin resistance (IR). Overexpressed miR-93 directly inhibits glucose transporter isoform 4, impairing both glucose metabolism and insulin sensitivity. The mechanisms behind increased miR-93 expression are unclear.
OBJECTIVE: Our objective was to determine whether miR-93 expression is concordant with its host gene, MCM7, which contains the miR-25/93/106b gene cluster. PATIENTS: AT was excised from 16 women with PCOS (eight with and eight without IR) and 15 non-PCOS (nine with and six without IR). MAIN OUTCOME MEASURES: Expression of MCM7 and miR-25/93/106b was measured in AT and 3T3-L1 cells.
RESULTS: MCM7 expression was lower in both non-PCOS/IR and PCOS women and tended to be lowest in women with PCOS and IR. Overall, the expression of MCM7 in human AT was negatively associated with miR-93 expression and with increased subject IR. Additionally, miR-25 and miR-106b expression is uncoupled from the MCM7 host gene and are positively correlated with IR, although no PCOS-specific difference was observed. MCM7 expression appears to be negatively correlated with increasing fasting glucose. In 3T3-L1 adipocytes, increasing glucose had no effect on miR-93 or miR-25, although it reduced MCM7 and increased miR-106b expression in a dose-dependent fashion. In turn, in 3T3-L1 adipocytes, increasing insulin had no effect on either MCM7 or miR-25/93/106b expression.
CONCLUSIONS: Our data suggest that the expression of MCM7 and miR-93/25 is PCOS and IR related, whereas that of miR-106b is related to IR only. In 3T3-L1 adipocytes, neither hyperglycemia nor hyperinsulinemia altered the expression of miR-93 or miR-25, although increasing glucose levels down-regulated MCM7 and paradoxically increased that of miR-106b expression. The expression of the miR-25/93/106b family may be regulated through mechanisms distinct from its host gene, MCM7. Finally, our studies suggest potential epigenetic mechanisms for both IR and PCOS.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25243570      PMCID: PMC4255124          DOI: 10.1210/jc.2013-4435

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  26 in total

1.  Prolonged insulin stimulation down-regulates GLUT4 through oxidative stress-mediated retromer inhibition by a protein kinase CK2-dependent mechanism in 3T3-L1 adipocytes.

Authors:  Jinhui Ma; Yuko Nakagawa; Itaru Kojima; Hiroshi Shibata
Journal:  J Biol Chem       Date:  2013-11-15       Impact factor: 5.157

2.  Cellular insulin resistance in adipocytes from obese polycystic ovary syndrome subjects involves adenosine modulation of insulin sensitivity.

Authors:  T P Ciaraldi; A J Morales; M G Hickman; R Odom-Ford; J M Olefsky; S S Yen
Journal:  J Clin Endocrinol Metab       Date:  1997-05       Impact factor: 5.958

3.  Induction of fatty acid synthetase synthesis in differentiating 3T3-L1 preadipocytes.

Authors:  A K Student; R Y Hsu; M D Lane
Journal:  J Biol Chem       Date:  1980-05-25       Impact factor: 5.157

Review 4.  Molecular defects of insulin action in the polycystic ovary syndrome: possible tissue specificity.

Authors:  T P Ciaraldi
Journal:  J Pediatr Endocrinol Metab       Date:  2000       Impact factor: 1.634

5.  Tissue insulin sensitivity and body weight in polycystic ovary syndrome.

Authors:  P J Marsden; A P Murdoch; R Taylor
Journal:  Clin Endocrinol (Oxf)       Date:  2001-08       Impact factor: 3.478

6.  Insulin resistance in polycystic ovary syndrome: decreased expression of GLUT-4 glucose transporters in adipocytes.

Authors:  D Rosenbaum; R S Haber; A Dunaif
Journal:  Am J Physiol       Date:  1993-02

7.  Cellular mechanisms of insulin resistance in polycystic ovarian syndrome.

Authors:  T P Ciaraldi; A el-Roeiy; Z Madar; D Reichart; J M Olefsky; S S Yen
Journal:  J Clin Endocrinol Metab       Date:  1992-08       Impact factor: 5.958

Review 8.  Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus.

Authors:  Fernando Ovalle; Ricardo Azziz
Journal:  Fertil Steril       Date:  2002-06       Impact factor: 7.329

9.  The prevalence and features of the polycystic ovary syndrome in an unselected population.

Authors:  Ricardo Azziz; Keslie S Woods; Rosario Reyna; Timothy J Key; Eric S Knochenhauer; Bulent O Yildiz
Journal:  J Clin Endocrinol Metab       Date:  2004-06       Impact factor: 5.958

10.  Does anovulation exist in eumenorrheic women?

Authors:  Christine E Malcolm; David C Cumming
Journal:  Obstet Gynecol       Date:  2003-08       Impact factor: 7.661

View more
  15 in total

1.  miRNA Profiling Reveals miRNA-130b-3p Mediates DENND1A Variant 2 Expression and Androgen Biosynthesis.

Authors:  Jan M McAllister; Angela X Han; Bhavi P Modi; Maria E Teves; Grace R Mavodza; Zachary L Anderson; Tsaiwei Shen; Lane K Christenson; Kellie J Archer; Jerome F Strauss
Journal:  Endocrinology       Date:  2019-08-01       Impact factor: 4.736

Review 2.  MicroRNA regulatory networks in human adipose tissue and obesity.

Authors:  Peter Arner; Agné Kulyté
Journal:  Nat Rev Endocrinol       Date:  2015-03-03       Impact factor: 43.330

3.  Serum-Derived Exosomal microRNAs in Lipid Metabolism in Polycystic Ovary Syndrome.

Authors:  Yanli Hong; Jiayun Wu; Simin Yu; Miao Hui; Sipei Lin
Journal:  Reprod Sci       Date:  2022-08-03       Impact factor: 2.924

4.  Combined androgen excess and Western-style diet accelerates adipose tissue dysfunction in young adult, female nonhuman primates.

Authors:  Oleg Varlamov; Cecily V Bishop; Mithila Handu; Diana Takahashi; Sathya Srinivasan; Ashley White; Charles T Roberts
Journal:  Hum Reprod       Date:  2017-09-01       Impact factor: 6.918

Review 5.  Epigenetic inheritance of polycystic ovary syndrome - challenges and opportunities for treatment.

Authors:  Elisabet Stener-Victorin; Qiaolin Deng
Journal:  Nat Rev Endocrinol       Date:  2021-07-07       Impact factor: 43.330

Review 6.  The role of miRNAs in polycystic ovary syndrome with insulin resistance.

Authors:  Yingliu Luo; Chenchen Cui; Xiao Han; Qian Wang; Cuilian Zhang
Journal:  J Assist Reprod Genet       Date:  2021-01-06       Impact factor: 3.412

7.  Hyperandrogenism and Metabolic Syndrome Are Associated With Changes in Serum-Derived microRNAs in Women With Polycystic Ovary Syndrome.

Authors:  Anja E Sørensen; Pernille B Udesen; Grzegorz Maciag; Julian Geiger; Negar Saliani; Andrzej S Januszewski; Guozhi Jiang; Ronald C Ma; Anandwardhan A Hardikar; Marie Louise M Wissing; Anne Lis M Englund; Louise T Dalgaard
Journal:  Front Med (Lausanne)       Date:  2019-11-01

8.  Increased expression of circulating miRNA-93 in women with polycystic ovary syndrome may represent a novel, non-invasive biomarker for diagnosis.

Authors:  T Sathyapalan; R David; N J Gooderham; S L Atkin
Journal:  Sci Rep       Date:  2015-11-19       Impact factor: 4.379

9.  Hyperglycemia Affects miRNAs Expression Pattern during Adipogenesis of Human Visceral Adipocytes-Is Memorization Involved?

Authors:  Justyna Strycharz; Ewa Świderska; Adam Wróblewski; Marta Podolska; Piotr Czarny; Janusz Szemraj; Aneta Balcerczyk; Józef Drzewoski; Jacek Kasznicki; Agnieszka Śliwińska
Journal:  Nutrients       Date:  2018-11-15       Impact factor: 5.717

10.  microRNA Expression in Women With and Without Polycystic Ovarian Syndrome Matched for Body Mass Index.

Authors:  Alexandra E Butler; Vimal Ramachandran; Thozhukat Sathyapalan; Rhiannon David; Nigel J Gooderham; Manasi Benurwar; Soha R Dargham; Shahina Hayat; S Hani Najafi-Shoushtari; Stephen L Atkin
Journal:  Front Endocrinol (Lausanne)       Date:  2020-04-28       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.